Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2007-07-31
2007-07-31
Foley, Shanon (Department: 1642)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S320100, C536S023100, C536S024300, C530S350000
Reexamination Certificate
active
09762577
ABSTRACT:
The invention features tumor antigens; tumor antigen-encoding nucleic acids; antibodies specific for tumor antigens and methods of using the antibodies; methods of identifying tumor antigens and the nucleic acids that encode them; methods of monitoring or diagnosing tumors in patients; methods of testing patients for the increased likelihood of developing a tumor; and methods and compositions for treatment of a tumor or prophylaxis against developing a tumor.
REFERENCES:
patent: 5840708 (1998-11-01), Weiss
patent: 6472172 (2002-10-01), Deng et al.
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Miller (1995, FASEB J., vol. 9, pp. 190-199).
Deonarain (1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69).
Verma (Sep. 1997, Nature, vol. 389, pp. 239-242).
Crystal (1995, Science, vol. 270, pp. 404-410).
Branch, AD, 1998, TIBS 23: 45-50.
Gura (Science, 1995, 270:575-577).
MPSRCH search report, 2006, us09-762-577b-11.rni, pp. 2-3; and.
MPSRCH search report, 2006, us-09-762-577b-12.p2n.rni, pp. 2-3.
White et al, 2001 (Ann Rev Med, 52: 125-145).
Boon, 1992 (Adv Can Res, 58:177-210).
Ezzell, 1995 (J. NIH Res, 7:46-49).
Spitler, 1995 (Cancer Biotherapy, 10:1-3).
Gura, 1997, (Science, 278:1041-1042).
Jain, 1994 (Sci. Am., 271:58-65).
Curti, 1993 (Crit. Rev. in Oncology/Hermatology, 14:29-39).
Hartwell et al (Science, 1997, 278:1064-1068).
Dranoff et al., “Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity,” Proc. Natl. Acad. Sci. U.S.A. 90:3539-3543, 1993.
Dranoff et al., “A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor,” Human Gene Therapy 7:111-123, 1997.
Ellem et al., “A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy,” Cancer Immunol. Immunother. 44:10-20, 1997.
Jäger et al., “Strategies for the development of vaccines to treat breast cancer,” Recent Results Cancer Res. (Germany) 152:94-102, 1998.
Scanlan et al., “Characterization of human colon cancer antigens recognized by autologous antibodies,” Int. J. Cancer 76:652-658, 1998.
Simons et al., “Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer,” Cancer Research 57:1537-1546, 1997.
Soffer et al., “Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma,” Proc. Natl. Acad. Sci. U.S.A. 95:13141-13146, 1998.
Takahashi et al., “707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma,” Clin. Cancer Res. 3:1363-1370, 1997.
Genbank Accession No. AI459806, Hillier et al., WashU-NCI human EST Project, Mar. 9, 1999.
Genbank Accession No. AI590782, NCI-CGAP http://www.ncbi.nih.gov
cicgap, National Cancer Institute, Cancer Genoma Anatomy Project (CGAP), Tumor Gene Index, May 14, 1999.
Genbank Accession No. AI115047, Marra et al., The WashU-HHMI Mouse EST Project, Sep. 2, 1998.
Dranoff Glenn
Hodi F. Stephen
Mollick Joseph
Schmollinger Jan
Bromberg & Sunstein LLP
Dana-Farber Cancer Institute
Davis Minh-Tam
Foley Shanon
LandOfFree
Tumor antigens and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor antigens and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor antigens and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758902